Cargando…

Neurofibromatosis type 1 comorbid with attention deficit and hyperactivity disorder. Case report

INTRODUCTION: A 9-year-old girl under pediatric follow-up since the age of 4 years after diagnosis of neurofibromatosis type 1 OBJECTIVES: To present a case of neurofibromatosis and ADHD comorbidity to raise awareness of the importance of screening for neurodevelopmental disorders. METHODS: Case rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Sol Calderón, P., Paricio Del Castillo, R., Mallol Castaño, L., Izquierdo De La Puente, A., Garcia Moreno, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567736/
http://dx.doi.org/10.1192/j.eurpsy.2022.1094
_version_ 1784809474916089856
author Del Sol Calderón, P.
Paricio Del Castillo, R.
Mallol Castaño, L.
Izquierdo De La Puente, A.
Garcia Moreno, M.
author_facet Del Sol Calderón, P.
Paricio Del Castillo, R.
Mallol Castaño, L.
Izquierdo De La Puente, A.
Garcia Moreno, M.
author_sort Del Sol Calderón, P.
collection PubMed
description INTRODUCTION: A 9-year-old girl under pediatric follow-up since the age of 4 years after diagnosis of neurofibromatosis type 1 OBJECTIVES: To present a case of neurofibromatosis and ADHD comorbidity to raise awareness of the importance of screening for neurodevelopmental disorders. METHODS: Case report and literature review RESULTS: The patient had an adequate control and follow-up of the disorder with periodic check-ups and magnetic resonance imaging during her follow-up. She was referred due to symptoms of inattention with failure to perform exams and impulsivity in interpersonal relationships, affecting her social functioning. In addition, the patient presented simple motor tics of eye contraction and shoulder elevation. The patient was diagnosed with attention deficit hyperactivity disorder together with tic disorder. She was treated with stimulant medication with worsening of tics and marked hyporexia. Therefore, medication with guanfacine was started up to 4 mg per day, adjusted by weight. With this dose there was a control of the tics, with improvement of the symptoms of inattention and impulsivity. In different spheres an improvement in their functionality was observed, with improvement in mood, self-esteem and academic performance. CONCLUSIONS: Neurofibromatosis type 1 is a rare monogenic disorder with a varied presentation (ophthalmologic, dermatologic and predisposition to tumor development). Patientshave been shown to present with symptoms of inattention and executive function impairment, along with other neurodevelopmental disorders such as autism spectrum disorders, learning disabilities or intellectual disability. The literature shows that up to 60% of them has ADHD criteria. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9567736
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95677362022-10-17 Neurofibromatosis type 1 comorbid with attention deficit and hyperactivity disorder. Case report Del Sol Calderón, P. Paricio Del Castillo, R. Mallol Castaño, L. Izquierdo De La Puente, A. Garcia Moreno, M. Eur Psychiatry Abstract INTRODUCTION: A 9-year-old girl under pediatric follow-up since the age of 4 years after diagnosis of neurofibromatosis type 1 OBJECTIVES: To present a case of neurofibromatosis and ADHD comorbidity to raise awareness of the importance of screening for neurodevelopmental disorders. METHODS: Case report and literature review RESULTS: The patient had an adequate control and follow-up of the disorder with periodic check-ups and magnetic resonance imaging during her follow-up. She was referred due to symptoms of inattention with failure to perform exams and impulsivity in interpersonal relationships, affecting her social functioning. In addition, the patient presented simple motor tics of eye contraction and shoulder elevation. The patient was diagnosed with attention deficit hyperactivity disorder together with tic disorder. She was treated with stimulant medication with worsening of tics and marked hyporexia. Therefore, medication with guanfacine was started up to 4 mg per day, adjusted by weight. With this dose there was a control of the tics, with improvement of the symptoms of inattention and impulsivity. In different spheres an improvement in their functionality was observed, with improvement in mood, self-esteem and academic performance. CONCLUSIONS: Neurofibromatosis type 1 is a rare monogenic disorder with a varied presentation (ophthalmologic, dermatologic and predisposition to tumor development). Patientshave been shown to present with symptoms of inattention and executive function impairment, along with other neurodevelopmental disorders such as autism spectrum disorders, learning disabilities or intellectual disability. The literature shows that up to 60% of them has ADHD criteria. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9567736/ http://dx.doi.org/10.1192/j.eurpsy.2022.1094 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Del Sol Calderón, P.
Paricio Del Castillo, R.
Mallol Castaño, L.
Izquierdo De La Puente, A.
Garcia Moreno, M.
Neurofibromatosis type 1 comorbid with attention deficit and hyperactivity disorder. Case report
title Neurofibromatosis type 1 comorbid with attention deficit and hyperactivity disorder. Case report
title_full Neurofibromatosis type 1 comorbid with attention deficit and hyperactivity disorder. Case report
title_fullStr Neurofibromatosis type 1 comorbid with attention deficit and hyperactivity disorder. Case report
title_full_unstemmed Neurofibromatosis type 1 comorbid with attention deficit and hyperactivity disorder. Case report
title_short Neurofibromatosis type 1 comorbid with attention deficit and hyperactivity disorder. Case report
title_sort neurofibromatosis type 1 comorbid with attention deficit and hyperactivity disorder. case report
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567736/
http://dx.doi.org/10.1192/j.eurpsy.2022.1094
work_keys_str_mv AT delsolcalderonp neurofibromatosistype1comorbidwithattentiondeficitandhyperactivitydisordercasereport
AT pariciodelcastillor neurofibromatosistype1comorbidwithattentiondeficitandhyperactivitydisordercasereport
AT mallolcastanol neurofibromatosistype1comorbidwithattentiondeficitandhyperactivitydisordercasereport
AT izquierdodelapuentea neurofibromatosistype1comorbidwithattentiondeficitandhyperactivitydisordercasereport
AT garciamorenom neurofibromatosistype1comorbidwithattentiondeficitandhyperactivitydisordercasereport